Image of the human circulatory system
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Hydrix (ASX:HYD) came out of left field on investors’ radars on Thursday, posting gains just south of +80% after the company inked a deal with NYSE-listed Picard Medical to kick off development of the latter’s ‘Total Artificial Heart.’

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

It was only two days ago Picard itself kicked off its TAH rollout, a product already ‘cleared’ by the FDA, which is being delivered by Picard subsidiary SynCardia. It is SynCardia that Hydrix has inked its deal with on Thursday.

The TAH product itself is described by Picard as an implant targeting patients with already-advanced heart degradation. According to the company, TAH “assumes the full functions of a failing or failed human heart.”

“With more than 2,100 implants performed at hospitals across 27 countries, the SynCardia Total Artificial Heart is the most widely used and extensively studied artificial heart in the world,” Picard wrote in a U.S.-market-facing release earlier this week.

So what’s Hydrix developing? SynCardia is developing a second-iteration TAH product called “The Emperor.” Ultimately, Hydrix is now sitting on a $2.5 million contract for completion in this calendar year. The company described this first $2.5M contract as an initial phase of a larger program on Thursday.

HotCopper users were net bullish on the news, with more than one forum user suggesting the market is overlooking Hydrix; for all intents and purposes, as far as this finance journalist’s day-by-day monitoring of markets goes, Hydrix is definitely one of the more obscure biotech stocks on the ASX.

But as 4DMedical (ASX:4DX) is currently evidencing, the biotech sector poses a vast opportunity when it comes to share price momentum.

HYD has a market cap below $7M; worth noting, today’s price momentum is on the back of $540K worth of trades, further evidencing the stock’s relative obscurity. 20.9M shares had traded hands compared to a 4Wavg of 233K.

HYD last traded at 2.3cps.

Join the discussion: See what HotCopper users are saying about Hydrix Ltd and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

hyd by the numbers
More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…
Easter bunny in a business suit analyzing stock charts, symbolizing market strategy

ASX closed for Easter long weekend. Enjoy your chocolates and the holiday break!

Yes, yes, I know you’re itching to do some serious Australian market trading today, but everyone — especially our much-loved HotCopper forum users